Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammation
Resource Type
Article
Authors
Sourris, Karly C. ; Ding, Yi ; Maxwell, Scott S. ; Al-sharea, Annas ; Kantharidis, Phillip ; Mohan, Muthukumar ; Rosado, Carlos J. ; Penfold, Sally A. ; Haase, Claus ; Xu, Yangsong ; Forbes, Josephine M. ; Crawford, Simon ; Ramm, Georg ; Harcourt, Brooke E. ; Jandeleit-Dahm, Karin ; Advani, Andrew ; Murphy, Andrew J. ; Timmermann, Daniel B. ; Karihaloo, Anil ; Knudsen, Lotte Bjerre ; El-Osta, Assam ; Drucker, Daniel J. ; Cooper, Mark E. ; Coughlan, Melinda T.
Source
In Kidney International January 2024 105(1):132-149
Subject
Language
ISSN
0085-2538